Supernus Announces Second Quarter 2023 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Supermicro probe finds no senior management link to export violations
- SpaceX shares fall as second lockup period ends
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
Supernus Pharma (SUPN) Misses Q2 EPS
August 8, 2023 4:36 PM EDTSupernus Pharma (NASDAQ: SUPN) reported Q2 GAAP EPS of ($0.02), which may not compare to the analyst estimate of $0.22. Revenue for the quarter came in at $135.56 million versus the consensus estimate of $144.53 million.
For earnings history and earnings-related data on Supernus Pharma (SUPN) click here.
... More